Genetic dissociation of opiate tolerance and physical dependence in δ-opioid receptor-1 and preproenkephalin knock-out mice

被引:0
|
作者
Nitsche, JF
Schuller, AGP
King, MA
Zengh, M
Pasternak, GW
Pintar, JE
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA
[2] Mem Sloan Kettering Canc Ctr, Neuropharmacol Lab, New York, NY 10021 USA
来源
JOURNAL OF NEUROSCIENCE | 2002年 / 22卷 / 24期
关键词
morphine; opiate; mu-opioid receptor; delta-opioid receptor; preproenkephalin; NMDA receptor; tolerance; dependence;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous experiments have shown that mice lacking a functional delta-opioid receptor (DOR-1) gene do not develop analgesic tolerance to morphine. Here we report that mice lacking a functional gene for the endogenous ligand preproenkephalin (ppENK) show a similar tolerance deficit. In addition, we found that the DOR-1 and ppENK knock-outs as well as the NMDA receptor-deficient 129S6 inbred mouse strain, which also lacks tolerance, exhibit antagonist-induced opioid withdrawal. These data demonstrate that although signaling pathways involving ppENK, DOR, and NMDA receptor are necessary for the expression of morphine tolerance, other pathways independent of these factors can mediate physical dependence. Moreover, these studies illustrate that morphine tolerance can be genetically dissociated from physical dependence, and thus provide a genetic framework to assess more precisely the contribution of various cellular and molecular changes that accompany morphine administration to these processes.
引用
收藏
页码:10906 / 10913
页数:8
相关论文
共 50 条
  • [1] Rapid induction of insulin resistance in opioid μ-receptor knock-out mice
    Cheng, JT
    Liu, IM
    Hsu, CF
    NEUROSCIENCE LETTERS, 2003, 339 (02) : 139 - 142
  • [2] Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in μ-opioid receptor knock-out mice
    Berrendero, F
    Kieffer, BL
    Maldonado, R
    JOURNAL OF NEUROSCIENCE, 2002, 22 (24): : 10935 - 10940
  • [3] Nociception increases during opioid infusion in opioid receptor triple knock-out mice
    Juni, A.
    Klein, G.
    Pintar, J. E.
    Kest, B.
    NEUROSCIENCE, 2007, 147 (02) : 439 - 444
  • [4] Regulation of δ-opioid receptor trafficking via μ-opioid receptor stimulation:: Evidence from μ-opioid receptor knock-out mice
    Morinville, A
    Cahill, CM
    Esdaile, MJ
    Aibak, H
    Collier, B
    Kieffer, BL
    Beaudet, A
    JOURNAL OF NEUROSCIENCE, 2003, 23 (12): : 4888 - 4898
  • [5] Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice
    Kest, B
    Hopkins, E
    Palmese, CA
    Chen, ZP
    Mogil, JS
    Pintar, JE
    NEUROSCIENCE, 2001, 104 (01) : 217 - 222
  • [6] Mu opiate receptor knock-out mice: Influence on pain, locomotion and reward models
    Sora, I
    Ii, XF
    Zeng, Z
    Kinsey, S
    Kitanaka, N
    Kitanaka, J
    Goodman, N
    Elmer, G
    Uhl, GR
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R347 - R347
  • [7] Decreased oral self-administration of alcohol in κ-opioid receptor knock-out mice
    Kovacs, KM
    Szakall, I
    O'Brien, D
    Wang, R
    Vinod, KY
    Saito, M
    Simonin, F
    Kieffer, BL
    Vadasz, C
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2005, 29 (05) : 730 - 738
  • [8] Naloxone fails to produce conditioned place aversion in μ-opioid receptor knock-out mice
    Skoubis, PD
    Matthes, HW
    Walwyn, WM
    Kieffer, BL
    Maidment, NT
    NEUROSCIENCE, 2001, 106 (04) : 757 - 763
  • [9] Opioid receptor gene expression in dopamine transporter knock-out mice in adult and during development
    Le Moine, C
    Fauchey, V
    Jaber, M
    NEUROSCIENCE, 2002, 112 (01) : 131 - 139
  • [10] Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice
    David, DJ
    Froger, N
    Guiard, B
    Przybylski, C
    Jego, G
    Boni, C
    Hunt, SP
    De Felipe, C
    Hamon, M
    Jacquot, C
    Gardier, AM
    Lanfumey, L
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 492 (01) : 41 - 48